← All organizations

Orphan Medical

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Aug 1, 2003

Acquired by Jazz Pharmaceuticals on Jan 1, 2005

Timeline

1990s

Jan 1, 1994
Orphan Medical— Founded
Apr 9, 1998
sacrosidase— NDA Organization

2000s

Jan 1, 2005
Jazz Pharmaceuticals— Acquired By

Drugs by trial phase (4 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

sodium oxybate

Phase 2 (1 own, 0 via acquisition)

betaine

Phase 1 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (3)

Recent trials (5)

NCT00058955Lead sponsorPhase 1Aug 1, 2003
NCT00586911CollaboratorPhase 2Jan 1, 2003
NCT00049803Study directorPhase 3Dec 1, 2000
NCT00049803Study chairPhase 3Dec 1, 2000
NCT00049803Lead sponsorPhase 3Dec 1, 2000

Details

Founded: Minnetonka, MN, US Jan 1, 1994
First NDA: Apr 9, 1998
Last known activity: Aug 1, 2003

Designations held

Orphan drug
Priority review